Halberd Corp (PK) (HALB) Quote

HALB:

Shocking 😆

I have--Heard anything more about that $2 million grant from ESC? It's been going into Spooz (SPZI). Randall's involved behind the curtain. A new front man installed Dec 8th. A/S completely maxed out yet new management claims they own ZERO shares (except the Super Vote). Their "YUGGE NEWS" always followed by a drop in share price. ESC= tax evasion and money laundering IMO

The ultimate scam continues.

Uh huh, suuuure.

This is one sucky Annual. Revenue Down, shares Up and soon, so will the AS's. (Be up)
And don't even get me started on those Judgements + Warrants.
Without a R/S, the PPS is going to find a home in the trips. Nobody is buying their shares now, wait until they are forced to step up the selling.
🤪

https://www.otcmarkets.com/stock/HALB/disclosure

$900 in daily volume
HALB=POS

Halberd & Athena GTX Report Initial Success of WatchDawg® PTSD Treatment Pilot Study
Press Release | 10/01/2024
JACKSON CENTER, Pa., Oct. 01, 2024 (GLOBE NEWSWIRE) -- Halberd Corporation (OTC PINK: HALB) released the results of the recently completed WatchDawg® Pilot Study. Ten (10) military veterans participated in the study where they received pharmaceuticals (LDX) and nutraceuticals, along with 24/7 access to mental health therapies provided by Yogani/Exalted Warrior Foundation. Participants wore a wrist monitor and used a mobile phone to upload vital sign data to the FDA-cleared Athena Device Management Suite (ADMS). Participant data was analyzed pre- and post-therapy. The study revealed consistent positive impact of the treatment with data indicating improved overall health.

During the study, various indicators of wellbeing were monitored in each participant via wearable technology developed by AthenaGTX, including, heart rate, blood oxygen level, respiration rate and skin temperature. Participants received troubleshooting support and participated in weekly Zoom calls with a physician to discuss system issues, problems, and anecdotal evidence. The program's details, objectives, and market summary were outlined in a prior press releases here and here.

Dr. Mark Darrah, CEO of Athena GTX, stated, “The results of this Pilot Study are very encouraging. We met all of our objectives set for this effort, helped the participants with improved health, and discovered ways we can improve the treatment methodology going forward. The proprietary LDX/CBN combination and specialized yoga/meditation positively impacted health and wellness, and the data acquisition system effectively supported participants. We will use what we learned plus feedback from participants to improve the treatment protocol as we proceed to a 100-patient Phase 1 clinical trial.”

Dr. Darrah continued, “As we enter the next programmed step, we wanted to remind any interested parties to consider enrolling in or supporting Phase 1 trials. This is an open invitation to witness first-hand the value and ease of the therapy and its impact.”

William A. Hartman, President and CEO of Halberd Corporation, added, “The results thus far indicate the treatment methodology is having very promising results in the long-term care and treatment of patients suffering from PTSD and associated physical health issues. We remain hopeful that this will result in a widely accepted standard of care.”

Note: The full Athena GTX WatchDawg press release can be accessed via this link.

To get the latest on Halberd’s exciting developments, subscribe by submitting this form.
(https://halberdcorporation.com/contact-us/).

For more information please contact:

William A. Hartman
w.hartman@halberdcorporation.com
support@halberdcorporation.com
www.halberdcorporation.com
Twitter: @HalberdC
0Halberd & Athena GTX Report Initial Success of WatchDawg® PTSD Treatment Pilot Study
Press Release | 10/01/2024
JACKSON CENTER, Pa., Oct. 01, 2024 (GLOBE NEWSWIRE) -- Halberd Corporation (OTC PINK: HALB) released the results of the recently completed WatchDawg® Pilot Study. Ten (10) military veterans participated in the study where they received pharmaceuticals (LDX) and nutraceuticals, along with 24/7 access to mental health therapies provided by Yogani/Exalted Warrior Foundation. Participants wore a wrist monitor and used a mobile phone to upload vital sign data to the FDA-cleared Athena Device Management Suite (ADMS). Participant data was analyzed pre- and post-therapy. The study revealed consistent positive impact of the treatment with data indicating improved overall health.

During the study, various indicators of wellbeing were monitored in each participant via wearable technology developed by AthenaGTX, including, heart rate, blood oxygen level, respiration rate and skin temperature. Participants received troubleshooting support and participated in weekly Zoom calls with a physician to discuss system issues, problems, and anecdotal evidence. The program's details, objectives, and market summary were outlined in a prior press releases here and here.

Dr. Mark Darrah, CEO of Athena GTX, stated, “The results of this Pilot Study are very encouraging. We met all of our objectives set for this effort, helped the participants with improved health, and discovered ways we can improve the treatment methodology going forward. The proprietary LDX/CBN combination and specialized yoga/meditation positively impacted health and wellness, and the data acquisition system effectively supported participants. We will use what we learned plus feedback from participants to improve the treatment protocol as we proceed to a 100-patient Phase 1 clinical trial.”

Dr. Darrah continued, “As we enter the next programmed step, we wanted to remind any interested parties to consider enrolling in or supporting Phase 1 trials. This is an open invitation to witness first-hand the value and ease of the therapy and its impact.”

William A. Hartman, President and CEO of Halberd Corporation, added, “The results thus far indicate the treatment methodology is having very promising results in the long-term care and treatment of patients suffering from PTSD and associated physical health issues. We remain hopeful that this will result in a widely accepted standard of care.”

Note: The full Athena GTX WatchDawg press release can be accessed via this link.

To get the latest on Halberd’s exciting developments, subscribe by submitting this form.
(https://halberdcorporation.com/contact-us/).

For more information please contact:

William A. Hartman
w.hartman@halberdcorporation.com
support@halberdcorporation.com
www.halberdcorporation.com
Twitter: @HalberdC

Halberd Partnership Secures Contract from Defense Atomics Corporation to Address Brain Injury and PTSD

JACKSON CENTER, Pa., Sept. 11, 2024 (GLOBE NEWSWIRE) -- Halberd Corporation (OTC PINK: HALB), in coordination with Athena Telemedicine Partners (ATP) and Athena GTX, Inc., is pleased to announce a substantial contract award commitment. Defense Atomics Corporation agreed to engage with the Halberd/Athena teams and to fund key advanced research, including the pending FDA IND study utilizing Halberd’s LDX technology and Athena Corporation’s WatchDawg™ monitoring technology.

Defense Atomics Corporation agreed to use its proprietary CRISPR/Nanotechnology Stem Cell treatment for PTSD/TBI in a minimum of 10 paid veterans in a government pilot study of this cutting-edge protocol. Based on Defense Atomics’ success using CRISPR methodology with overseas patients, this study is intended to substantiate the benefits of this technology in conjunction with Halberd/Athena’s LDX PTSD and TBI/Brain Injury protocol.

https://finance.yahoo.com/news/halberd-partnership-secures-contract-defense-120000500.html

Ohhh, a tenderfoot.

Resorting to name calling. Wow tough guy. :) Here's your previous quote> "Sure. Have not owned a share of this for over 6 years now." So get the f out then. :)

Nice try?? Doofus. The HALB PR is still promoting them as an active element of their program. Take a look at the years and the pps. This is cooked hogwash. I wish your your sake it wasn't, but it is.

Defense Atomics Corp has been out for a long time. Old news but nice try. We ALL know Athena GTX is paving the way. :) .

Seems the naysayers had it right all along. Fools and their past money, parted a LONG time ago.

Especially in light of the fact that Defense Atomics Corp does not exist as a company anymore. Has not for quite a while.

" anecdotal evidence " That's why the PR fell flat. Sad, but true.

Good results from a problem that reaches worldwide. I'm already to see it hit a buck or get bought out. :)

Halberd & Athena GTX Report Initial Success of WatchDawg® PTSD Treatment Pilot Study

Ten Military Veteran Volunteers Participated in the Pilot Study Enabled by Athena GTX Health Monitoring System

Jackson Center, PA October 1, 2024 – Halberd Corporation (OTC-PINK: "HALB”) released the results of the recently completed WatchDawg® Pilot Study. Ten (10) military veteran participated in the study where they received pharmaceuticals (LDX) and nutraceuticals, along with 24/7 access to mental health therapies provided by Yogani/Exalted Warrior Foundation. Participants wore a wrist monitor and used a mobile phone to upload vital sign data to the FDA-cleared Athena Device Management Suite (ADMS). Participant data was analyzed pre- and post-therapy. The study revealed consistent positive impact of the treatment with data indicating improved overall health.

During the study, various indicators of wellbeing were monitored in each participant via wearable technology developed by AthenaGTX, including, heart rate, blood oxygen level, respiration rate and skin temperature. Participants received troubleshooting support and participated in weekly Zoom calls with a physician to discuss system issues, problems, and anecdotal evidence. The program's details, objectives, and market summary were outlined in a prior press releases here and here.

Dr. Mark Darrah, CEO of Athena GTX, stated, “The results of this Pilot Study are very encouraging. We met all of our objectives set for this effort, helped the participants with improved health, and discovered ways we can improve the treatment methodology going forward. The proprietary LDX/CBN combination and specialized yoga/meditation positively impacted health and wellness, and the data acquisition system effectively supported participants. We will use what we learned plus feedback from participants to improve the treatment protocol as we proceed to a 100-patient Phase 1 clinical trial.”

Dr. Darrah continued, “As we enter the next programmed step, we wanted to remind any interested parties to consider enrolling in or supporting Phase 1 trials. This is an open invitation to witness first-hand the value and ease of the therapy and its impact.

William A. Hartman, President and CEO of Halberd Corporation, added, “The results thus far indicate the treatment methodology is having very promising results in the long-term care and treatment of patients suffering from PTSD and associated physical health issues. We remain hopeful that this will result in a widely accepted standard of care.”

mdiConsultants guiding the FDA clearance path

LDX will be on the market soon

Another 100 patient test will follow

New PR with test resulta

TOTAL NONSENSICAL B.S.



"While we have observed statistically compelling results in PTSD/TBI management using CRISPR," says CEO Dr. Gabe Vlad of Defense Atomics Corp., "the ability to significantly integrate our treatment protocols with those of Halberd/Athena's medication and monitoring technologies is quite attractive. The WatchDawg monitoring allows us to acquire near real time (NRT) objective data with respect to the administration of CRISPR. From the preliminary data, there's no question that theadds clear adjunctive relief."



The "LDX formulation" is an old failed drug see replied to post and the following:

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2880945/





There is

Good Day my friend. I believed we both learned back at BEBI, to take that profit and run.
As apposed to bagholding, or even worse, bagholding and try to keep other bagholders supporting your loosing position. 😜

They bought during the great HALB pump of 2021, I'm guessing around .05.-10 and have been holding the bag ever since...

Damn Squid, has any of these pathetically immature "investors" below realize 'Defense Atomics' is a fake company shell? We try to warn them fairly, and they just cuss and make threats, (BTW make them to my face scam-ees!) And they keep holding for dear life on this junk. Sue what's left of the fake Halberd clowns, maybe get more than what the current pps is right now.

Good lord.

Well, no one flips the POS better than you:)

This one I bash since it's' been a scam since company inception, and that last PR reads like a bad deep fake. For no other reason. Proven scams I don't forget.
Losers hang on when others warn them. I don't bash any stock much at all, not even ones that are just performance dogs, but if they are proven scams like HALB (?) No problem and I don't do it often either.

Bug off kid. Adults here now to protect your $$$, if you have any left at this point.

Sure. Have not owned a share of this for over 6 years now. After researching it closely, and discovering all of the scam operations, I go out at even money. The rest of you, I feel sorry for.

Your little blastoff rocket is grounded at this :"launch site".

LMAO!

You forgot bashing for cheap shares. (Just look at the volume. lol)
Who has to bash and then sit for who knows how long, on a bag of nothing? (Dead money is one of the dumbest things in Stinky Pinky Land.) SMH
Just wait for the PR and buy some. Hold for 5 mins. and release.

Just waiting for news...
Gobble up those cheapies they won't be here long...
Just waiting on those government contracts...
HALB to the moon...
Did I miss any?

That's right - when the PPS is manipulated down like this, load up. These game-playing schmendriks are doing longs a favor.

Couldn't remember exactly when Hartless brought the show to this ticker, but approx. https://www.barchart.com/stocks/quotes/HALB/interactive-chart

Yep, we know what is about to happen. lol
Play the bounces.

You are really tryin to get the share price down huh. Yeah if it drops I’m going to thank you for getting me more cheapies before it blows up. Keep talking bad about HALB. Everyone knows what’s about to happen 🚀

Been the same central message here for 9 years now.

A very poorly written PR. "Dr Vlad" (??) This sounds as bad as another couple of scams we've been monitoring. Anyone even attempt to get an email confirmation from 'Dr. Vlad" ??

Maybe with the bad grammar and misspellings, lack of corroboration, one may think this a scam PR?

Oh no, not here....

MM is shaking the tree. :) Lock those shares up boys.

I saw that. It's all coming together. :)

Halberd Partnership Secures Contract from Defense Atomics Corporation to Address Brain Injury and PTSD
8:00 AM ET 9/11/24 | GlobeNewswire
Halberd Partnership Secures Contract from Defense Atomics Corporation to Address Brain Injury and PTSD

Contributing Funding and a Significant Additional Tool to Combat PTSD and TBI

JACKSON CENTER, Pa., Sept. 11, 2024 (GLOBE NEWSWIRE) -- Halberd Corporation (OTC PINK: HALB), in coordination with Athena Telemedicine Partners (ATP) and Athena GTX, Inc., is pleased to announce a substantial contract award commitment. Defense Atomics Corporation agreed to engage with the Halberd/Athena teams and to fund key advanced research, including the pending FDA IND study utilizing Halberd's LDX technology and Athena Corporation's WatchDawg(TM) monitoring technology.

Defense Atomics Corporation agreed to use its proprietary CRISPR/Nanotechnology Stem Cell treatment for PTSD/TBI in a minimum of 10 paid veterans in a government pilot study of this cutting-edge protocol. Based on Defense Atomics' success using CRISPR methodology with overseas patients, this study is intended to substantiate the benefits of this technology in conjunction with Halberd/Athena's LDX PTSD and TBI/Brain Injury protocol.

"While we have observed statistically compelling results in PTSD/TBI management using CRISPR," says CEO Dr. Gabe Vlad of Defense Atomics Corp., "the ability to significantly integrate our treatment protocols with those of Halberd/Athena's medication and monitoring technologies is quite attractive. The WatchDawg monitoring allows us to acquire near real time (NRT) objective data with respect to the administration of CRISPR. From the preliminary data, there's no question that the LDX formulation adds clear adjunctive relief."

Dr. Mark Darrah, of Athena GTX added: "The early results of WatchDawg in LDX therapy are compelling and show that dovetailing therapies of many different forms with real data in brain health studies may hold the key to FDA clearance." He added, "It is much harder to argue against near real time data as opposed to mere recollections of subjective observations alone."

"We look forward to expanded use of LDX, and now that we can actually see the results documented by the WatchDawg technology in military veterans, the benefit in many modalities is limitless," says CEO of Halberd Corporation, William A. Hartman. Hartman continued, "Having commercial packaging of LDX and potentially CRISPR will allow us to market to physician groups even without formal FDA approval under current compounding laws, particularly with our access to, and relationships with, reputable and qualified compounding facilities. This product is useful for myriad disorders from PTSD, anxiety, depression, anger and addiction, to Chronic Covid, Alzheimer's, Chronic Kidney Disease (CKD), diabetes, and others. It has been shown to be remarkably without side-effects. These benefits are unique and extremely important to a successful endeavor. We now have a large quantity of commercially available product (LDX), enabling our team to aggressively market LDX to physician groups, hospitals, rehab centers...and something we haven't discussed and will expand on shortly, animal hospitals and clinics. This finally gives us great potential for real income and a go-to-market capability with actual product. This cannot at this point go directly to consumers, and must go through physicians, which is a potential market. Until then, the physician will be highly incentivized to utilize LDX, so that's a plus."

"While CRISPR is limited in FDA usage in the United States," ATP's Dr. Richard Goulding explains, "the FDA is looking for well-conceived studies to prove efficacy, particularly in areas where little to no other remedy is offered (Right to Try). LDX alone should be a go-to adjunct to all patients with anxiety and PTSD," says Dr. Goulding, adding, "we welcome the opportunity to clinically verify it."

Dr. Vlad added: "I have analyzed the preliminary data offered by the first tranche of patients from the WatchDawg pilot study, and realized that this is clearly the best fit for further research and justification for our CRISPR technology to be used in PTSD and those suffering brain injury. With WatchDawg, we can prove efficacy, or at least support it, all while demonstrating safety and efficacy from initial therapeutic intervention forward. What's exciting to me is the ability to see, thanks to the WatchDawg monitoring technology, real-time therapeutic effects on the individual. With WatchDawg, we would know immediately when something is working or not working, while quantitatively providing real-time data. That's a game changer. We have recently been awarded significant cash contracts and are thrilled to be able to have the funds to engage in this exciting trial with our new partners. Helping veterans suffering from suicidal ideation and PTSD has always been my fondest wish, especially since I am myself a veteran."

Dr. Vlad reports that "Defense Atomics Corp. successfully engineered specialty proprietary stem cells for this endeavor. Essentially what CRISPR does is to collect and utilize the patient's own blood and performs an extremely unique proprietary gene-editing process combined with stem cells to facilitate their goals. Historical results on patients have been quite compelling. I am committed to funding this study with Halberd/Athena. There are still significant regulatory hurdles to overcome, but we have the right personnel on board now to navigate these hurdles. Obviously, the key is to get the FDA the data and information they need to move this treatment forward. We also want veterans suffering from PTSD to have LDX available to them at low cost, so their medical teams can procure it from our existing charity, Stemofhope.com, since we have a commercial quantity of LDX available and all of the high-tech products utilized in the WatchDawg program monitoring platforms."

How large is the Market?

Databridgemarketresearch.com reports the global market for Post-Traumatic Stress Disorder (PTSD) treatments experienced steady growth. As of 2022

Keep loading these cheapies as they won't last long >> The 3rd PR will be out any day now, hopefully with much better news, that will drive the pps much higher into multiple pennies.

The last time it went down to .0032 it quickly bounced back and went to .0121 high.

DOD contracts will be announced soon and that will be the real game changer....ride to Silver ranges at the minimum.

there is 3 prs

It closed down on "good news" . Was busy, but guessing the translation is "here comes the next round of shares". SMH
We'll see, but expecting tomorrow we'll see OTCN on top of the Ask.

PS: The reasoning behind breaking into 2 PR's is, what ever doesn't sell with the 1st one, we expect to sell from the 2nd one.

More great news from Halberd Corp - this PPS is a great place to load more cheap shares.
Even our nay-saying board-shit-heads (you know who you are) can't refute the many positives happening with this innovative company!

https://halberdcorporation.com/halberd-letter-to-shareholders-patented-ldn-evolves-into-watchdawg-for-veteran-suicide-reduction/

And now Retired Early will cuss and swear a lot that his dung-heap isn't getting any more golden.
This is about to hit below .005 and get moldy there for another year.

Just when you think "you can't make this stuff up", someone does.
SMH

HALB was not awarded $700,000
"The DoD extended an invitation for us to submit a full application or proposal."
They were awarded the opportunity to submit an application for for research funding based on a white paper submitted...

Huge News Out!!! Dept. Of Defense (DOD) selected and awarded initial funding $700k to Halbert...much more to come.
https://finance.yahoo.com/news/halberd-corp-issues-letter-shareholders-120000153.html

Aero-man, broke on HALB, and destined to slide down the toilet with HALB. HALB's next mis-directed invention: A new Anal-Lube that serves as both a birth control for women, and an ED cure for Men. It's going to be called, "Aero-manless" and be sold in Walmart by X-mas!